Schedule is Subject to Change

Guidelines Meetings, 12:00 pm ET 10/2/19 – 12:00 pm ET 10/3/19

 

THURSDAY, OCTOBER 3

ALLIED HEALTH AND EARLY CAREER PROFESSIONAL PRE-CONFERENCE

10:00 am – 12:00 pm
Allied Health 1
10:00 am – 11:00 am Building a Multidisciplinary Team

Moderator: Robin Sommers, DNP, ANP, ACNP, AOCNP, Dana-Farber Cancer Institute

Panelists:

Bonnie Bennett, RN, BSN, University of Pennsylvania 

Angela Laffan, NP, MSN, University of California San Francisco

Aman Chauhan, MD, Markey Cancer Center

Hillary Wright, MEd, RD, LDN, Dana-Farber Cancer Institute 

Jane Bausch, MSW, LICSW, Dana-Farber Cancer Institute

11:00 am – 11:10 am Q&A
11:10 am – 11:50 am Financial Toxicity
Aman Chauhan, MD, Markey Cancer Center
11:50 am – 12:00 pm Q&A
12:30 pm – 1:30 pm
NETworking Round-Table Lunch- Join NANETS Board Members, Consensus Guidelines Committee, Allied Health and Early Career colleagues for lunch and round-table discussions on key NET issues
1:30 pm – 3:00 pm
Allied Health 2

Moderator: Bonnie Bennett, RN, BSN, University of Pennsylvania

1:30 pm – 2:10 pm Hereditary Syndromes in NET
Anu Chittenden MS, LGC, Dana-Farber Cancer Institute
2:10 pm – 2:15 pm Q&A
2:15 pm – 2:55 pm Fertility in Cancer/Survivorship
Allison Ruhe, PA-C, Brigham and Women’s Hospital
2:55 pm – 3:00 pm Q&A
1:30 pm – 3:00 pm
Early Career 1
Moderators: Simron Singh, MD, MPH, FRCPC, Odette Cancer Center, Sunnybrook Health Sciences Centre; and Jennifer Chan, MD, MPH, Dana-Farber Cancer Institute
1:30 pm – 2:15 pm

Young Investigator Presentations (Best of…)

Samantha Greenberg, MS, MPH, CGC, University of Utah

Jessica Maxwell, MD, MD Anderson Cancer Center

Rohit Gosain, MD, Roswell Park Comprehensive Cancer Center

2:15 pm – 2:30 pm Building an Independent Basic Research Program
James Bibb, Ph.D., University of Alabama Birmingham Medical Center
2:30 pm – 2:45 pm

Building an Independent Health Services Research Program 
Simron Singh, MD, MPH, FRCPC, Odette Cancer Center, Sunnybrook Health Sciencesentre

2:45 pm – 3:00 pm Q&A
3:00 pm – 3:30 pm Break
3:30 pm – 5:00 pm
Allied Health 3
Moderator: Angela Laffan, NP, MSN, University of California San Francisco
3:30 pm – 3:55 pm Carcinoid Syndrome: Pathophysiology, Diagnosis and Management Robin Sommers, DNP, ANP, ACNP, AOCNP, Dana-Farber Cancer Institute
3:55 pm – 4:00 pm Q&A
4:00 pm – 4:25 pm Carcinoid Heart Disease, Robyn Silberman, NP, Stanford University 
4:25 pm – 4:30 pm Q&A Presentation, Diagnosis & Management
4:30 pm – 4:55 pm Liver-Directed Therapies, Diana Van Houten, CRNP, University of Pennsylvania
4:55 pm – 5:00 pm Q&A
3:30 pm – 5:00 pm
Early Career 2
Moderators: Eric Nakakura, MD, Ph.D., University of California San Francisco, and Michael Soulen, MD, University of Pennsylvania, Abramson Cancer Center
3:30 pm – 4:15 pm

Young Investigator Presentations (Best of…)

Jina Nanayakkara, MD, Ph.D, Queens University 

Aman Chauhan, MD, University of Kentucky 

Chandra Kumar Maharjan, University of Iowa

4:15 pm – 4:30 pm Designing and Running a Clinical Trial Marianne Pavel, MD, Friedrich-Alexander Universität Erlangen-Nürnberg
4:30 pm – 4:45 pm Strategies for Success: Altruism, Failure and Being a Good Mentee,  Michael Soulen, MD, University of Pennsylvania, Abramson Cancer Center
4:45 pm – 5:00 pm Q&A
5:00 pm – 6:00 pm Welcome to Boston NETworking Reception

 

FRIDAY, OCTOBER 4

CONFERENCE DAY 1

7:30 am – 8:30 am
Breakfast
7:30 am – 8:30 am
Welcome to Boston/Conference Opening
Welcome to Boston/Conference Opening: James Howe, MD, University of Iowa, Carver College of Medicine, Simron Singh, MD, MPH, FRCPC, Odette Cancer Center, Sunnybrook Health Sciences Centre, and Eric Nakakura, MD, Ph.D., University of California San Francisco
8:40 am – 9:00 am
NET Year in Review
Robert Jensen, MD, National Institute of Health
9:00 am – 10:00 am
Keynote Research Lecture
Stress Management During Tumor Initiation and Progression
Keynote Presentation by: Joan S. Brugge, MD, Ph.D., Harvard Medical School Intro and Moderator: Dawn Quelle, Ph.D., University of Iowa, Carver College of Medicine
10:00 am – 10:30 am
Break
10:30 am – 11:30 am
NANETS/SNMMI
Moderators: Ghassan El-Haddad, MD, Moffitt Cancer Center and Erik Mittra, MD, Ph.D., Oregon Health & Science University
10:30 am – 10:45 am Future of NET Imaging Andrei H. Iagaru, MD, Stanford School of Medicine
10:45 am – 11:00 am Current Clinical Considerations of PRRT: Ghassan El-Haddad, MD, Moffitt Cancer Center
11:00 am – 11:15 am Future Applications of PRRT: Lisa Bodei, MD, Ph.D., Memorial Sloan Kettering Cancer Center
11:15 am – 11:30 am Q&A
11:30 am – 12:30 pm
Featured Abstracts 1 - Basic/Translational Abstracts

Moderators: Daniel Halperin, MD, MD Anderson, and Jennifer Chan, MD, MPH, Dana-Farber Cancer Institute

Aaron Scott, MD, University of Iowa Hospital Hospitals and Clincis: Differential Gene Expression in Metastatic Pancreatic Neuroendocrine Tumors Predicts Novel Therapeutic Agents

Mauro Cives, MD, University of Bari: Development of Anti-SSTR Car T Cells for Future Treatment of NETS

Ume Salma Shaik Amjad, MD, Unversity of Iowa: CDK-Targeted Combination Therapies of Pancreatic Neuroendocrine Tumors (PNETS) Guided By RABL6A-Dependent Regulation of the PNET Kinome and Phosphoproteome

Rozita Bagheri-Yarman, MD, The University of Texas MD Anderson Cancer Center: Imipridone ONC201 Blocks Tumor Growth by Inhibiting Ret/Igfbp2 Pathway in Medullary Thyroid Cancer

12:30 pm – 2:00 pm
Lunch Symposium: Serotonin Pathophysiology Mechanistic Roles and Therapeutic Strategy

Daniel Halperin, MD, MD Anderson Cancer Center

2:00 pm – 2:55 pm
Patient-Centered Care in NETs
Moderators: Simron Singh, MD, MPH, FRCPC, Odette Cancer Center, Sunnybrook Health Sciences Centre, and Angela Laffan, NP, University of California San Francisco
2:00 pm – 2:15 pm Patient-Reported Issues in NETs: Rachel Goodwin, MD, FRCPC, University of Ottawa
2:15 pm – 2:30 pm Cognitive Issues in NETs: Janice Pasieka, MD, FRC SC, FACS, University of Calgary
2:30 pm – 2:45 pm Decision Making in NETS: How to be Patient-Centric: Marianne Pavel, MD, Friedrich-Alexander Universität Erlangen-Nürnber
2:55 pm – 3:00 pm Q&A
3:00 pm – 4:00 pm
Pheochromocytoma and Paraganglioma
Moderators: Emily Bergsland, MD, University of California San Francisco and Lauren Fishbein, MD, Ph.D., University of Colorado
3:00 pm – 3:15 pm Advances in Therapeutic Management of P/P and MIBG: Daniel Pryma, MD, University of Pennsylvania
3:15 pm – 3:30 pm Control of Hormonal Syndromes for P/P: Camilo Jimenez, MD, MD Anderson Cancer Center
3:30 pm – 3:45 pm Genomic Landscape of P/P: Lauren Fishbein, MD, Ph.D., University of Colorado
3:45 pm – 4:00 pm Q&A
3:00 pm – 4:00 pm
NANETS Meets SIO
Why Fix What Isn’t Broken? When to Consider Systemic Therapies for Liver-Dominant Disease
Moderators: Michael Soulen, MD, University of Pennsylvania, Abramson Cancer Center; and Sarah White, MD, University of Wisconsin
3:00 pm – 3:10 pm What We Do and Don’t Know About Response and TTP for Liver Metastases: Embolotherapy, PRRT, and Systemic Drugs: Michael Soulen, MD, University of Pennsylvania, Abramson Cancer Center
3:10 pm – 3:40 pm Panel Discussion: Patient-Centered Care: Who Gets What, and When?
Panelists:
  • Etay Ziv, MD, Ph.D., Memorial Sloan Kettering Cancer Center
  • Nicholas Fidelman, MD, University of California San Francisco
  • Jennifer Eads, MD, University of Pennsylvania
  • Juan Valle, MBChB, MSc FRCP, University of Manchester
  • Ghassan El-Haddad, MD, Moffitt Cancer Center
  • Heather Jacene, MD, Harvard Medical School, Dana-Farber Cancer Institute
3:40 pm – 4:00 pm
Debate: Intra-Arterial PRRT - Does It Make Sense in 2019?
  • Pro — Nicholas Fidelman, MD, University of California San Francisco
  • Con — Ghassan El-Haddad, MD, Moffitt Cancer Center​
4:00 pm – 4:15 pm
Break
4:15 pm – 5:15 pm
Future Treatments in NETS
Moderators: Thorvardur Halfdanarson, MD, Mayo Clinic, and James Yao, MD, MD Anderson
4:15 pm – 4:30 pm Advances in G3
Emily Bergsland, MD University of California San Francisco>
4:30 pm – 4:45 pm New Agents
Jaume Capdevila, MD, Vall d’Hebron Institute of Oncology
4:45 pm – 5:00 pm Carcinoid Heart Disease
Juan Valle, MB, ChB, MSc, FRCP, University of Manchester
5:00 pm – 5:15 pm Q&A
5:15 pm – 5:45 pm
Oberndorfer Cup Competition — NET Quiz
Moderators: Michael Soulen, MD, University of Pennsylvania, Abramson Cancer Center; and Simron Singh, MD, MPH, FRCPC, Odette Cancer Center, Sunnybrook Health Sciences Centre
5:45 pm – 7:00 pm
Poster Reception
Poster walks hosted by: David Metz, MD, University of Pennsylvania and Dermot O’Toole, MD, FRCPI, St. James Hospital and Trinity College
   

 

SATURDAY, OCTOBER 5

CONFERENCE DAY 2

7:15 am – 8:00 am
Breakfast
8:00 am – 9:00 am
NANETS Annual Meeting, Grant Awards and Recognition
James Howe, MD, University of Iowa, Carver College of Medicine
9:10 am – 10:10 am
Lung NET
Moderators: Robert Ramirez, DO, FACP, Ochsner Medical Center, and Pam Kunz, MD, Stanford Cancer Center
9:10 am – 9:25 am Management in DIPNECH Sukhmani Padda, MD, Stanford University
9:25 am – 9:40 am PRRT in Lung NET – What is Its Role
Thomas Hope, MD, University of California San Francisco
9:40 am – 9:55 am Operative Management of Lung NETs
Natalie Lui, MD, Stanford University
9:55 am – 10:10 am Q&A
10:10 am – 11:10 am
Research Didactic Session
Bill Kaelin, MD, Dana-Farber Cancer Institute
Ramesh Shivdasani, MD, Ph.D., Dana-Farber Cancer Institute and Harvard Medical School
Trevor Pugh, Ph.D., University of Toronto
11:10 am – 11:30 am
Break
11:15 am – 12:00 pm
Tumor Board
Moderators: Rodney Pommier, MD, Oregon Health & Science University (Chair); and
Jonathan Strosberg, MD, Moffitt Cancer Center

Panelists:

  • Thomas Clancy, MD, Brigham and Women’s Hospital
  • Juan Valle, MBChB, MSc, FRCP, University of Manchester
  • Michael Soulen, MD, University of Pennsylvania, Abramson Cancer Center
  • Rachel Goodwin, MD, FRCPC, University of Ottawa

Case 1: Bart Rose, MD, MAS, University of Alabama Birmingham Medical Center
Case 2: Aman Chauhan, MD, University of Kentucky Healthcare

12:00 pm - 1:20 pm
Lunch Symposium

12:00 - 12:20 - Lunch

12:20 - 12:50 - Post Lunch Education: Moderator: Michael Soulen, MD, University of Pennsylvania

Embolotherapy: Can We Refine the Guidelines?

  • TAE vs. TACE: Matthew P. Schenker, MD, Brigham and Women’s Hospital
  • cTACE vs. DEB TACE: Suvranu Ganguli, MD, Massachusetts General Hospital
  • TACE vs. TARE: Juan-Carlos Perez-Lozada, MD, Yale University

12:50 - 1:20 Post Educational Session . . Ask the Experts: PRRT Round Table
Thorvardur Halfdanarson, MD, Mayo Clinic; Thomas Hope, MD, University of San Francisco| Daniel Pryma, MD, University of Pennsylvania; Jonathan Strosberg, MD, Moffitt Cancer Center, and Amanda Abbott, MS, CNMT, RT(N)(CT), PET, Dana Farber Cancer Institue

1:30 pm – 2:30 pm
Featured Abstracts 2 – Clinical Abstracts
Moderators: Simron Singh, MD, MPH, FRCPC, Odette Cancer Center, Sunnybrook Health Sciences Centre; and James Howe, MD, University of Iowa, Carver College of Medicine
2:30 pm – 3:15 pm
Optimal Management of Localized Gastric and Rectal NETs
Panel: Eric Nakakura, MD, Ph.D., University of California, San Francisco (Chair); David Metz, MD, University of Pennsylvania; Nelya Melnitchouk, MD, Brigham and Women’s Hospital; Kimberly Perez, MD, Dana-Farber Cancer Institute; and Dermot O’Toole, MD, FRCPI, St. James Hospital and Trinity College
3:15 pm – 4:00 pm
NET Medical Debates
Moderators: David Metz, MD, University of Pennsylvania, and Jonathan Strosberg, MD, Moffitt Cancer Center
3:15 pm – 3:35 pm Surgery is the Best First Approach for Liver Predominant Liver NETS

PRO: James Howe, MD, University of Iowa, Carver College of Medicine

CON: Diane Reidy-Lagunes, MD, Memorial Sloan Kettering Cancer Center

3:35 pm – 3:55 pm Does Immunotherapy Have a Future in NETS?

PRO: Marianne Pavel, MD, Charite - Friedrich-Alexander Universität Erlangen-Nürnberg

CON: Juan Valle, MBChB, MSc, FRCP, University of Manchester

4:00 pm
Closing Remarks and Announcement of 2020 NANETS Symposium
James Howe, MD, University of Iowa, Carver College of Medicine